mebendazole has been researched along with Rectal Diseases in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Rectal Diseases: Pathological developments in the RECTUM region of the large intestine (INTESTINE, LARGE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burns, DG | 1 |
| Hayes, MM | 1 |
1 other study available for mebendazole and Rectal Diseases
| Article | Year |
|---|---|
Rectal spirochaetosis--symptomatic response to metronidazole and mebendazole. A case report.
Topics: Benzimidazoles; Homosexuality; Humans; Male; Mebendazole; Metronidazole; Middle Aged; Rectal Disease | 1985 |